Bothell-based biotech Athira Pharma (Nasdaq: ATHA) has appointed Grant Pickering, CEO and co-founder of the California-based vaccine company Vaxcyte, to its board of directors. “Grant is an accomplished life sciences leader with considerable experience across all stages of development and commercialization of new medicines,” Mark Litton, president and CEO at Athira, said in a news release. “His […]

Athira Pharma has dosed the first patient in its Phase 2 clinical trial evaluating ATH-1017 as a treatment for Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB) — forms of more severe cognitive impairment in Parkinson’s disease. The trial (NCT04831281), known as SHAPE, is still recruiting patients, ages 40-85, at five different locations across the United […]

The U.S. Food and Drug Administration (FDA) has given positive feedback to Annovis Bio’s plans to start two Phase 3 clinical trials of buntanetap (ANVS401) as an oral therapy for early- and late-stage Parkinson’s disease. The feedback followed a review of data from a Phase 2 clinical trial showing significant gains in motor skills among early Parkinson’s patients treated once […]